Genentech asks FDA to approve eye drug
Published by MSN Search News: "Food and Drug Administration" December 31st, 2005 in Regulatory AffairsEast Bay Business Times - Genentech Inc. said Friday that it has asked the to approve the marketing of Lucentis, its treatment for an eye condition that quickly causes blindness among the elderly. The drug developer (NYSE: DNA), which is based in …